Levnibiot (Levofloxacin)

Levofloxacin is a broad‑spectrum fluoroquinolone antibiotic used to treat bacterial infections in several organ systems.

• Community‑acquired respiratory tract infection: reduces bacterial load and improves symptoms such as cough and fever.
• Urinary tract infection: eradicates susceptible uropathogens and resolves dysuria and urgency.
• Skin and soft tissue infection: eliminates causative bacteria, promoting healing of cellulitis and abscesses.
• Acute bacterial sinusitis: clears sinus inflammation caused by susceptible organisms, relieving congestion and facial pain.
• Acute bacterial pharyngitis: treats streptococcal and other bacterial throat infections, alleviating sore throat and fever.

• Levofloxacin exerts its antibacterial activity by binding to bacterial DNA gyrase (topoisomerase II) and topoisomerase IV. This inhibition prevents the supercoiling and relaxation of DNA that are essential for replication and transcription, leading to bacterial cell death. The drug displays concentration‑dependent killing and a post‑antibiotic effect against a wide range of Gram‑negative and Gram‑positive organisms. Its high oral bioavailability allows effective systemic concentrations after a single tablet dose.

Levofloxacin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools, sometimes watery.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness or imbalance.

Serious or Rare Side Effects

• Tendon rupture: sudden pain or swelling, especially in the Achilles tendon.
• QT interval prolongation: cardiac rhythm changes that may lead to arrhythmia.
• Severe hypersensitivity: rash, Stevens‑Johnson syndrome, or anaphylaxis.

Before prescribing Levofloxacin, clinicians should evaluate patient risk factors and follow safety guidelines.

• Assess renal function: dose adjustment may be required in impaired clearance.
• Review history of tendon disorders: avoid in patients with recent tendon injury or corticosteroid use.
• Monitor cardiac status: caution in individuals with known QT prolongation or electrolyte disturbances.
• Avoid use in pregnancy and lactation unless benefits outweigh risks, due to unknown safety data.
• Counsel patients on photosensitivity: advise protection from excessive sunlight.
• Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Levofloxacin interacts with several medicines; awareness of major and moderate interactions helps prevent adverse events.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate dosing by at least 2 hours.
• Warfarin: may increase INR and bleeding risk; monitor coagulation parameters closely.
• Theophylline: elevated plasma levels can cause toxicity; consider dose reduction.

Moderate Interactions (Monitor Closely)

• NSAIDs: may increase risk of central nervous system stimulation.
• Diabetic agents (e.g., insulin, sulfonylureas): levofloxacin can enhance hypoglycemia; monitor blood glucose.
• Corticosteroids: combined use may raise tendon rupture risk; advise patient vigilance.